New Data Supporting Potential of ADG20 for Both the Treatment and Prevention of COVID–19 to be Presented at IDWeek 2021
Patient Population in Global EVADE Phase 2/3 Clinical [...] Read more »
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using [...] Read more »